Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design ; volume:24 ; number:1 ; day:7 ; month:5 ; year:2024 ; pages:1-10 ; date:12.2024
BMC geriatrics ; 24, Heft 1 (7.5.2024), 1-10, 12.2024
- Creator
-
Yang, Tianchi
Tang, Ling
Li, Pingping
Li, Baojun
Ye, Lixia
Zhou, Jifang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12877-024-05003-3
- URN
-
urn:nbn:de:101:1-2407180750035.171094130928
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yang, Tianchi
- Tang, Ling
- Li, Pingping
- Li, Baojun
- Ye, Lixia
- Zhou, Jifang
- SpringerLink (Online service)
Other Objects (12)
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy